कृपया अन्य खोज का प्रयास करें
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company’s clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a small molecule inhibiting the biological activity of ETS-family transcription factor oncoproteins, which is in Phase 1/2 clinical trial. It is also developing ONCT-808, a chimeric antigen receptor T-cells (CAR-T), which is in Phase 1/2 clinical trial for the treatment of hematologic malignancies and solid tumors, as well as targets ROR1; and ONCT-534, a dual-action androgen receptor inhibitor product candidate in preclinical development for the treatment of castration-resistant prostate and other androgen receptor-driven cancers. The company has license agreements with the Regents of the University of California; Georgetown University; The University of Texas MD Anderson Cancer Center; Shanghai Pharmaceutical (USA) Inc.; and University of Tennessee Research Foundation. Oncternal Therapeutics, Inc. is headquartered in San Diego, California.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
David F. Hale | 75 | 2019 | Independent Chairman of the Board |
Daniel L. Kisner | 77 | 2019 | Independent Director |
Thomas Kipps | - | - | Scientific Advisor |
Robert James Wills | 70 | 2019 | Non-Independent Director |
Xin Nakanishi | 62 | 2019 | Independent Director |
Gunnar F. Kaufmann | 47 | 2019 | Prostate Cancer & Cell Therapy Scientific Advisory Board Member |
Charles P. Theuer | 60 | 2019 | Independent Director |
James B. Breitmeyer | 70 | 2019 | President, CEO & Director |
Michael G. Carter | 86 | 2006 | Independent Director |
William R. LaRue | 73 | 2019 | Independent Director |
Angela Shen | - | 2021 | Cell Therapy Scientific Advisory Board Member |
Jill M. DeSimone | 68 | 2023 | Independent Director |
Rosemary Mazanet | 68 | 2021 | Independent Director |
Sadik Kassim | 43 | 2021 | Cell Therapy Scientific Advisory Board Member |
Michael Wang | - | 2021 | Cell Therapy Scientific Advisory Board Member |
Johann De Bono | - | 2023 | Prostate Cancer Scientific Advisory Board Member |
Marcela V. Maus | 47 | 2021 | Cell Therapy Scientific Advisory Board Member |
Evan Ya-Wen Yu | - | 2023 | Prostate Cancer Scientific Advisory Board Member |
Matthew R. Smith | - | 2023 | Prostate Cancer Scientific Advisory Board Member |
Howard R. Soule | - | 2023 | Prostate Cancer Scientific Advisory Board Member |
Scott Dehm | - | 2023 | Prostate Cancer Scientific Advisory Board Member |
Ramesh Narayanan | - | 2023 | Scientific Advisors |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है